CollaGenex to net $43M from stock sale
16th Nov 2006, 15:12 GMT
CollaGenex Pharmaceuticals Inc. entered into definitive agreements with institutional and other investors Thursday to sell 3.5 million shares of common stock for $45.5 million.
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- Spectrum Pharmaceuticals gets $5M milestone payment, settles with GlaxoSmithKline
- Corautus Genetics chips at Q3 loss
- Spherix hoping to brush its sweet tooth
- Auxilium added to NASDAQ's biotech index
- CombinatoRx reports revenue boost
- Alexion gets fast-track FDA review for drug Soliris
- InnoCentive identifies a new CEO
- Digene names new CEO
- Dynamic Health dips into the red
- Sigma-Aldrich elects Paul to board